Sirio Pharma to acquire Best Formulations
Best Formulation’s City of Industry complex will now serve as Sirio’s North American headquarters once the transaction is completed.
Photo © iStockphoto.com/MarsBars
Sirio Pharma Co. Ltd. (Shantou, Guangdong, China) has acquired 80% of the equity of Best Formulations Inc. (City of Industry, CA). Best Formulations specializes in the contract manufacturing of softgels in North America, as well as the manufacturing and commercialization of vitamins, minerals, plant-based nutritional supplements and personal care products.
“This is a significant milestone in Sirio’s strategy to establish a global manufacturing footprint. By adding Best’s world-class North American manufacturing facilities to our established bases in Asia and Europe, the combined company will be able to better serve both our global and regional customers with local production everywhere they want to be,” said Doug Brown, managing director of Sirio Americas.
Best Formulation’s City of Industry complex will now serve as Sirio’s North American headquarters once the transaction is completed.
“Our entire team is very excited to join the Sirio family in a shared mission of providing our customers with world-class service and innovative products. This combination will allow us to grow our business faster with global resources and capabilities,” said Eugene Ung, CEO of Best Formulations.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
